Breadcrumb
Dokumente & Medien
The development of a core outcomes set for self-management interventions for patients living with obesity
The development of a core outcomes set for self-management interventions for patients living with obesity
Version 1.1 Genehmigt- Dokumententyp
- EXTERNAL_DOCUMENT
- Erweiterung
- png
- Größe
- 210 KB
- Geändert
- 21.10.22 13:25 von mir mir
- Erstellt
- 21.10.22 13:19 von mir mir
- Ort
- PUBLIC
- Bewertungen
-
-
Version 1.1Von mir mir, am 21.10.22 13:25Kein Änderungsprotokoll
-
Version 1.0Von mir mir, am 21.10.22 13:19Kein Änderungsprotokoll
Kurzfassung
Self-management interventions (SMIs) can improve the life of patients living with obesity. However, there is variability in the outcomes used to assess the effectiveness of SMIs and these are often not relevant for patients. In the context of COMPAR-EU, our aim was to develop a core outcome set (COS) for the evaluation of SMIs for patients with obesity. We followed a four steps multimethod approach: (1) the development of the initial catalogue of outcomes; (2) a scoping review of reviews on patients' values and preferences on outcomes of self-management (SM); (3) a Delphi survey including patients and patient representatives to rate the importance of outcomes; and (4) a 2-day consensus workshop with patients, patient representatives, healthcare professionals and researchers. The initial catalogue included 82 outcomes. Ten patients and patient's representatives participated in the Delphi survey. We identified 16 themes through the thematic synthesis of the scoping review that informed 37.80% of the outcomes on initial catalogue. Five patients, five healthcare professionals, and four researchers participated in the consensus workshop. After the consensus process, 15 outcomes were selected to be part of the final COS, and five supplementary outcomes were also provided. We developed a COS for the evaluation of SMIs in obesity with a significant involvement of patients and other key stakeholders. This COS will help improving data synthesis and increasing the value of SM research data in healthcare decision making.
Das COMPAR-EU-Projekt wurde durch das Forschungs- und Innovationsprogramm Horizont 2020 der Europäischen Union unter der Fördervereinbarung Nr. 754936 gefördert.
Sie enthält jetzt die vollständigen Ergebnisse für Diabetes, und im Laufe des Sommers 2022 werden die Ergebnisse für Adipositas, COPD und Herzinsuffizienz vervollständigt. Die Plattform wird auch in den nächsten Monaten erweitert und verbessert.